A novel device helps prevent HIV
Region: Global
Circumcising 20 million men in sub-Saharan Africa by 2015 could prevent 3.4 million HIV infections, but by March 2012, only 1.5 million men had received voluntary medical male circumcision services. In sub-Saharan Africa, FHI 360 is collaborating with EngenderHealth and Weill Cornell Medical College to assess the ShangRing — a novel device for performing male circumcision that uses no stitches and results in little or no bleeding. In 2012, FHI 360 and its partners completed a series of studies in Kenya and Zambia showing that the method was as safe as conventional surgery and offered an easier, faster procedure with higher rates of client satisfaction. An independent committee will review the study results and make recommendations to the World Health Organization on whether to endorse wider use of the ShangRing.
Funder: Bill & Melinda Gates Foundation
